ROYAL BANK OF CANADA - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$319,000
-35.9%
73,809
-2.1%
0.00%
Q2 2023$498,000
+6.6%
75,409
+9.8%
0.00%
Q1 2023$467,000
+191.9%
68,648
+216.2%
0.00%
Q4 2022$160,000
-23.8%
21,711
+2.2%
0.00%
Q3 2022$210,000
-8.3%
21,235
+1.3%
0.00%
Q2 2022$229,000
-3.0%
20,955
+0.2%
0.00%
Q1 2022$236,000
-30.6%
20,906
-3.3%
0.00%
Q4 2021$340,000
-8.6%
21,622
-0.3%
0.00%
Q3 2021$372,000
-17.5%
21,680
+3.5%
0.00%
Q2 2021$451,000
+43.6%
20,947
+0.1%
0.00%
Q1 2021$314,000
-35.5%
20,928
-43.5%
0.00%
Q4 2020$487,000
+23.9%
37,034
-8.8%
0.00%
Q3 2020$393,000
-4.4%
40,598
+13.2%
0.00%
Q2 2020$411,000
+105.5%
35,854
+85.7%
0.00%
Q1 2020$200,000
+545.2%
19,303
+940.0%
0.00%
Q4 2019$31,000
+34.8%
1,856
+6.1%
0.00%
Q3 2019$23,000
-14.8%
1,750
-7.4%
0.00%
Q2 2019$27,000
-22.9%
1,890
-0.6%
0.00%
Q1 2019$35,000
-52.7%
1,902
-33.0%
0.00%
Q4 2018$74,000
+19.4%
2,840
+6.3%
0.00%
Q3 2018$62,000
+24.0%
2,671
+1.1%
0.00%
Q2 2018$50,000
-18.0%
2,643
-27.6%
0.00%
Q1 2018$61,000
+3.4%
3,649
-6.0%
0.00%
Q4 2017$59,000
-54.3%
3,880
-46.1%
0.00%
Q3 2017$129,000
+126.3%
7,194
+104.7%
0.00%
Q2 2017$57,000
+16.3%
3,515
+0.3%
0.00%
Q1 2017$49,000
-34.7%
3,506
-25.1%
0.00%
Q4 2016$75,000
+29.3%
4,680
+33.7%
0.00%
Q3 2016$58,000
+107.1%
3,500
+40.0%
0.00%
Q2 2016$28,000
-67.8%
2,500
-76.0%
0.00%
Q1 2016$87,000
-10.3%
10,400
-0.6%
0.00%
Q4 2015$97,000
-31.7%
10,462
-17.2%
0.00%
Q3 2015$142,000
+54.3%
12,628
+73.9%
0.00%
Q2 2015$92,000
+16.5%
7,260
-14.6%
0.00%
Q1 2015$79,000
-35.2%
8,5000.0%0.00%
Q4 2014$122,000
+47.0%
8,500
+6.2%
0.00%
Q3 2014$83,000
-35.7%
8,0000.0%0.00%
Q2 2014$129,000
+3.2%
8,000
+3.9%
0.00%
Q1 2014$125,000
+101.6%
7,700
+54.0%
0.00%
Q4 2013$62,000
-91.6%
5,000
-92.5%
0.00%
-100.0%
Q3 2013$734,000
+118.5%
67,084
+61.3%
0.00%
Q2 2013$336,00041,6000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders